ArticleCirculation reports2026

Evaluation of the 1-Year Efficacy and Tolerability of Inclisiran in Coronary Artery Disease Patients.

Shigeyasu Tsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.